The clinically approved antiviral drug sofosbuvir impairs brazilian zika virus replication

Zika virus (ZIKV) is a member of Flaviviridae family, as other agents of clinical significance, such as dengue (DENV) and hepatitis C (HCV) viruses. ZIKV spread from Africa to Pacific and South American territories, emerging as an etiological pathogen of neurological disorders, during fetal development and in adulthood. Therefore, antiviral drugs able to inhibit ZIKV replication are necessary. Broad spectrum antivirals, such as interferon, ribavirin and favipiravir, are harmful for pregnant animal models and women. The clinically approved uridine nucleotide analog anti-HCV drug, sofosbuvir, has not been affiliated to teratogenicity. Sofosbuvir target the most conserved protein over the members of the Flaviviridae family, the viral RNA polymerase. We thus studied ZIKV susceptibility to sofosbovir. We initially characterized a Brazilian ZIKV strain for use in experimental assays. Sofosbuvir inhibits the Brazilian ZIKV replication in a dose-dependent manner, both in BHK-21 cells and SH-Sy5y, by targeting ZIKV RNA polymerase activity, with the involvement of conserved amino acid residues over the members of Flaviviridae family. The identification of clinically approved antiviral drugs endowed with anti-ZIKV could reduce the time frame in pre-clinical development. Altogether, our data indicates that sofosbuvir chemical structure is endowed with anti-ZIKV activity.

• Publication year

  2016

• Venue

  bioRxiv

• Publication date

  2016-07-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/061671
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.

  2016cited by this paper
• Quantitative proteomics study of the neuroprotective effects of B12 on hydrogen peroxide-induced apoptosis in SH-SY5Y cells

  2016cited by this paper
• Chloroquine inhibits Zika Virus infection in different cellular models

  2016cited by this paper
• Zika virus in the Americas: Early epidemiological and genetic findings

  2016cited by this paper
• A Susceptible Mouse Model for Zika Virus Infection

  2016cited by this paper
• Mitochondrial disease therapy from thin air?

  2016cited by this paper
• Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study.

  2016cited by this paper
• Zika Virus.

  2016influential reference
• Zika virus and neurological disease—approaches to the unknown

  2016cited by this paper
• Zika virus and Guillain-Barré syndrome: another viral cause to add to the list.

  2016cited by this paper
• Nucleoside Inhibitors of Zika Virus.

  2016cited by this paper
• Zika virus in the Americas: Early epidemiological and genetic findings

  2016cited by this paper
• Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities.

  2016influential reference
• Zika Virus Infection in Pregnant Women in Rio de Janeiro — Preliminary Report

  2016influential reference
• Zika virus impairs growth in human neurospheres and brain organoids

  2016influential reference
• Clinical Manifestations of Zika Virus Infection, Rio de Janeiro, Brazil, 2015

  2016cited by this paper
• Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

  2016cited by this paper
• The Viral Polymerase Inhibitor 7-Deaza-2’-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model

  2016cited by this paper
• Zika Virus: Diagnostics for an Emerging Pandemic Threat

  2016cited by this paper
• A Mouse Model of Zika Virus Pathogenesis.

  2016cited by this paper
• Zika Virus and Birth Defects--Reviewing the Evidence for Causality.

  2016influential reference
• Zika Virus: A New Animal Model for an Arbovirus

  2016cited by this paper
• Quantitative Proteomic Analysis of BHK-21 Cells Infected with Foot-and-Mouth Disease Virus Serotype Asia 1

  2015cited by this paper
• Potential Sexual Transmission of Zika Virus

  2015cited by this paper
• Structural basis for RNA replication by the hepatitis C virus polymerase

  2015influential reference
• Molecular basis for specific viral RNA recognition and 2′-O-ribose methylation by the dengue virus nonstructural protein 5 (NS5)

  2015cited by this paper
• Proteomic Analysis of Membrane Proteins of Vero Cells: Exploration of Potential Proteins Responsible for Virus Entry

  2014cited by this paper
• Recent highlights in the synthesis of anti-HCV ribonucleosides.

  2014cited by this paper
• Sofosbuvir: A novel treatment option for chronic hepatitis C infection

  2014cited by this paper
• Informed and automated k-mer size selection for genome assembly

  2013cited by this paper
• PEAR: a fast and accurate Illumina Paired-End reAd mergeR

  2013cited by this paper
• Assembling Single-Cell Genomes and Mini-Metagenomes From Chimeric MDA Products

  2013cited by this paper
• Crystal Structure of the Full-Length Japanese Encephalitis Virus NS5 Reveals a Conserved Methyltransferase-Polymerase Interface

  2013cited by this paper
• Adamts-18 Is a Novel Candidate Gene Of Vascular Development That Is Related To Aggravated Thrombosis: Evidence From a Adamts-18 Knock Out Mice

  2013cited by this paper
• Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation.

  2013cited by this paper
• Quality control and preprocessing of metagenomic datasets

  2011cited by this paper
• Fast Identification and Removal of Sequence Contamination from Genomic and Metagenomic Datasets

  2011cited by this paper
• A performance enhanced PSI-BLAST based on hybrid alignment

  2011cited by this paper
• Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone.

  2008cited by this paper
• Crystal Structure of the RNA Polymerase Domain of the West Nile Virus Non-structural Protein 5*

  2007cited by this paper
• The modeled structure of the RNA dependent RNA polymerase of GBV-C Virus suggests a role for motif E in Flaviviridae RNA polymerases

  2005cited by this paper
• ExPASy: the proteomics server for in-depth protein knowledge and analysis

  2003cited by this paper
• Site-specific mutagenesis by triple helix-forming oligonucleotides containing a reactive nucleoside analog.

  2003cited by this paper
• Adverse effects and other safety aspects of the hepatitis C antivirals

  2000cited by this paper
• CAP3: A DNA sequence assembly program.

  1999cited by this paper
• VERIFY3D: assessment of protein models with three-dimensional profiles.

  1997cited by this paper
• Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity.

  1996cited by this paper
• Comparative protein modelling by satisfaction of spatial restraints.

  1993cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

  1988cited by this paper
• Zika virus. I. Isolations and serological specificity.

  1952cited by this paper

• COVID-19 Associated Mortality and Cardiovascular Disease Outcomes Among U.S. Women Veterans

  2020cites this paper
• Sofosbuvir as a potential option for the treatment of COVID-19

  2020cites this paper
• Efficacy and safety of sofosbuvir/ledipasvir in treatment of patients with COVID-19; A randomized clinical trial

  2020cites this paper
• Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

  2020cites this paper
• Bioinformatics Methods to Discover Antivirals Against Zika Virus

  2019cites this paper
• Zika virus infection in pregnant women in a General Hospital of Veracruz, Mexico

  2019cites this paper
• Emergence of the East-Central-South-African genotype of Chikungunya virus in Brazil and the city of Rio de Janeiro may have occurred years before surveillance detection

  2018cites this paper
• Zika virus outbreak: a review of neurological complications, diagnosis, and treatment options

  2018cites this paper
• Synergistic antiviral activity of Sofosbuvir and type‐I interferons (α and β) against Zika virus

  2018cites this paper
• Cell-line dependent antiviral activity of sofosbuvir against Zika virus.

  2017cites this paper
• Bibliometric Indicators of the Zika Outbreak

  2017cites this paper
• Zika clinical updates: implications for pediatrics

  2017cites this paper
• Sofosbuvir: an antiviral drug with potential efficacy against Zika infection.

  2017cites this paper
• Zika Virus: An Emerging Global Health Threat

  2017cites this paper
• Molecular dynamics simulation revealed binding of nucleotide inhibitors to ZIKV polymerase over 444 nanoseconds

  2017cites this paper
• The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication

  2017cites this paper
• N-(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives, synthesized by thermal and ultrasonic means, are endowed with anti-Zika virus activity.

  2017cites this paper
• Clinical Trials of Therapeutics for the Prevention of Congenital Zika Virus Disease: Challenges and Potential Solutions

  2017cites this paper
• Therapeutic Approaches for Zika Virus Infection of the Nervous System

  2017cites this paper
• Epidemiology, Prevention, and Potential Future Treatments of Sexually Transmitted Zika Virus Infection

  2017cites this paper
• 2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine.

  2017cites this paper
• Analysis of Ribonucleotide 5′-Triphosphate Analogs as Potential Inhibitors of Zika Virus RNA-Dependent RNA Polymerase by Using Nonradioactive Polymerase Assays

  2016cites this paper
• Zika and Other Emerging Viruses: Aiming at the Right Target

  2016cites this paper
• Zika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials

  2016cites this paper
• Zika virus cell tropism in the developing human brain and inhibition by azithromycin

  2016cites this paper